Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Biorestorative Therapies Inc (BRTX)

$0.41 +0.07 (22.07%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	8.65M
Revenue (ttm)	360,000.00
Net Income (ttm)	-14.24M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3,955.56%
Debt to Equity Ratio	0.00

Volume	2,945,900
Avg Vol	13,361,018
Day's Range	N/A - N/A
Shares Out	25.48M
Stochastic %K	46%
Beta	0.67
Analysts	Strong Sell
Price Target	$8.00

Company Profile

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral di...

Industry: Biotechnology

Sector: Healthcare

Phone: 631 760 8100

Website: www.biorestorative.com

Address:

40 Marcus Drive, Suite 1, Melville, United States

Marc_Trades Jun. 5 at 12:25 AM

$BRTX come on, lets go!... at least run to $1

0 · Reply

MrWhiskIt Jun. 4 at 10:02 PM

$BRTX Yeah definitely bull trap

0 · Reply

Nonideal Jun. 4 at 7:57 PM

$BRTX

0 · Reply

alrightx3 Jun. 4 at 7:03 PM

$BRTX can we please get a legit run here....

0 · Reply

Trtrucking79 Jun. 4 at 5:31 PM

$BRTX .

1 · Reply

MrWhiskIt Jun. 4 at 5:22 PM

$BRTX Bull trap

2 · Reply

Amoreoq Jun. 4 at 3:15 PM

$BRTX

0 · Reply

Hd88sport Jun. 3 at 5:35 PM

$BRTX Borrow Rate 365.81%

2 · Reply

Dsradoff720 Jun. 3 at 3:29 PM

$BRTX a million short shares are active again it looks like.

1 · Reply

Dsradoff720 Jun. 3 at 2:50 PM

$BRTX new release! https://biorestorative.com/biocosmeceuticals/

0 · Reply

BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals

2026-05-07T17:39:05.000Z - 4 weeks ago

BioRestorative Therapies reports expanded Phase 2 blinded dataset for BRTX-100

May 7, 2026, 12:00 PM EDT - 4 weeks ago

BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease

Apr 30, 2026, 10:36 AM EDT - 5 weeks ago

BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform

Apr 24, 2026, 7:00 AM EDT - 5 weeks ago

BioRestorative Therapies Slides: Corporate presentation

2026-04-21T13:19:35.000Z - 6 weeks ago

BioRestorative Therapies announces partnership with David Goldberg, M.D.

Apr 21, 2026, 8:00 AM EDT - 6 weeks ago

BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform

Apr 13, 2026, 8:00 AM EDT - 7 weeks ago

BioRestorative Therapies Proxy statement: Proxy filing

2026-04-07T14:23:38.000Z - 2 months ago

BioRestorative Therapies announces strategic collaboration with 203 Creates

Apr 7, 2026, 8:15 AM EDT - 2 months ago

BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform

Apr 3, 2026, 8:00 AM EDT - 2 months ago

BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease

Mar 26, 2026, 7:00 AM EDT - 2 months ago

BioRestorative Therapies Annual report: Q4 2025

Mar 19, 2026, 8:00 AM EDT - 2 months ago

BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease

BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026

Mar 5, 2026, 8:00 AM EST - 3 months ago

BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs

BioRestorative Announces Closing of $5.0 Million Public Offering

Feb 13, 2026, 8:30 PM EST - 3 months ago

BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market

2025-10-22T13:40:37.000Z - 8 months ago

BioRestorative Therapies names Crystal Romano head, global commercial operations

Oct 22, 2025, 9:35 AM EDT - 8 months ago

BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio

BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit

Oct 15, 2025, 9:35 AM EDT - 8 months ago

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates

Jun 17, 2025, 9:25 AM EDT - 1 year ago

BioRestorative Announces Share Repurchase Program

Jun 13, 2025, 7:45 AM EDT - 1 year ago

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025

Jun 9, 2025, 7:45 AM EDT - 1 year ago

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities

Apr 10, 2025, 9:15 AM EDT - 1 year ago

BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States

BioRestorative Therapies Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program

BioRestorative Therapies Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

BioRestorative Therapies' IFATS 2024 Presentation to Feature ThermoStem® Platform's Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs

BioRestorative Therapies Quarterly report: Q2 2024

Aug 13, 2024, 10:00 AM EDT - 1 year ago

BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program

Jun 17, 2024, 7:05 AM EDT - 2 years ago

BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results

Jun 13, 2024, 7:00 AM EDT - 2 years ago

BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program

Jun 4, 2024, 8:50 AM EDT - 2 years ago

BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference

May 24, 2024, 7:45 PM EDT - 2 years ago

BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice

May 15, 2024, 9:00 AM EDT - 2 years ago

BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market

BioRestorative Therapies Provides First Quarter 2024 Business Update

May 14, 2024, 4:10 PM EDT - 2 years ago

BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology

Apr 16, 2024, 7:45 AM EDT - 2 years ago

BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment

Apr 12, 2024, 8:00 AM EDT - 2 years ago

BioRestorative Therapies Registration statement: Registration Filing

Apr 8, 2024, 7:45 AM EDT - 2 years ago

BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease

Marc_Trades Jun. 5 at 12:25 AM

$BRTX come on, lets go!... at least run to $1

0 · Reply

MrWhiskIt Jun. 4 at 10:02 PM

$BRTX Yeah definitely bull trap

0 · Reply

Nonideal Jun. 4 at 7:57 PM

$BRTX

0 · Reply

alrightx3 Jun. 4 at 7:03 PM

$BRTX can we please get a legit run here....

0 · Reply

Trtrucking79 Jun. 4 at 5:31 PM

$BRTX .

1 · Reply

MrWhiskIt Jun. 4 at 5:22 PM

$BRTX Bull trap

2 · Reply

Amoreoq Jun. 4 at 3:15 PM

$BRTX

0 · Reply

Hd88sport Jun. 3 at 5:35 PM

$BRTX Borrow Rate 365.81%

2 · Reply

Dsradoff720 Jun. 3 at 3:29 PM

$BRTX a million short shares are active again it looks like.

1 · Reply

Dsradoff720 Jun. 3 at 2:50 PM

$BRTX new release! https://biorestorative.com/biocosmeceuticals/

0 · Reply

Tuskdog Jun. 3 at 12:24 PM

$BRTX do I see a cup forming?!?!?!

1 · Reply

Tuskdog Jun. 3 at 12:22 PM

$BRTX time for some “green“ days! 🤜🏻🔝🤛🏻

0 · Reply

Dickman777 Jun. 2 at 7:48 PM

$BRTX running into the fire again, determined to find the bottom here, shorts in control until they are not, but when this does go i won’t be chasing!! 🤝

0 · Reply

Tuskdog Jun. 2 at 7:41 PM

$BRTX dang it I may have just missed another buying opportunity at 34. Ugh.

0 · Reply

Hd88sport Jun. 2 at 6:58 PM

$BRTX are they actively diluting?

0 · Reply

APEYOU Jun. 2 at 4:35 PM

$BRTX this POS AIS GETTING DESLISTED AT THIS RATE

0 · Reply

TheBigDawgRoman Jun. 2 at 4:01 PM

$BRTX sweet, we're next

0 · Reply

TheBigDawgRoman Jun. 2 at 3:43 PM

$BRTX lol drop of 22% since your post

1 · Reply

rsewkumar01 Jun. 2 at 3:31 PM

$BRTX Added more at this level!

0 · Reply

TheBigDawgRoman Jun. 2 at 3:23 PM

$BRTX Where'd you go lmao

0 · Reply

Dickman777 Jun. 2 at 2:51 PM

$BRTX entered again .35 needs to stay above .34 for me!

1 · Reply

Hd88sport Jun. 2 at 2:00 PM

$BRTX need news and fast

0 · Reply

1.0.0